Skip to main content
. Author manuscript; available in PMC: 2016 Oct 20.
Published in final edited form as: J Am Coll Cardiol. 2015 Oct 20;66(16):1779–1787. doi: 10.1016/j.jacc.2015.08.023

TABLE 4.

Clinical Predictors of Mortality

Hazard Ratio* (95%CI) p Value
Pre-transplant LVEF 0.73 (0.67–0.81) <0.001
Pre-transplant LVM/BSA 1.20 (0.95–1.50) 0.129
Pre-transplant LVDd 1.25 (0.96–1.60) 0.090
Multivariable Model (corrected for age, sex, race, dialysis duration, eGRF at 12 months)
 Pre-transplant LVEF 0.61 (0.49–0.78) <0.001
 Improved LVEF ≥ 10% 0.46 (0.21–0.93) 0.031
 Δ Hemoglobin 0.65 (0.49–0.87) 0.004
*

Hazard ratio per 1 standard deviation increment for continuous variables.

Pre-transplant LVEF was assessed in all 1,375 patients who had a pre-transplant echocardiogram.

Censor time was calculated from the date of post-transplant echo and not date of transplant, to reduce possible confounding.

Abbreviations as in Tables 1, 2, and 3.